Active, not recruitingNot applicableNCT05064514
Investigation of a Transcatheter Tricuspid Valved Stent Graft in Patients With Carcinoid Heart Disease
Studying Carcinoid syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Queen Mary University of London
- Principal Investigator
- Andreas BaumbachQueen Mary University of London
- Intervention
- Transcatheter Tricuspid Valved Stent Graft(device)
- Enrollment
- 15 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2028
Study locations (1)
- Barts Health NHS Trust, London, England, United Kingdom
Collaborators
Royal Free Hospital NHS Foundation Trust
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05064514 on ClinicalTrials.govOther trials for Carcinoid syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07087054Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine RegimenCrinetics Pharmaceuticals Inc.
- RECRUITINGNCT05756608Fibrosis in Chronic and Delayed Myocardial InfarctionUniversity of Edinburgh
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT04993261An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid TumorsM.D. Anderson Cancer Center